cGAS inhibitors for Alzheimer's disease treatment

Subhash Sinha

Más información

Fecha de publicación: 2021
Objetivos: ABSTRACT Alzheimer's disease (AD) is the most common form of dementia in elderly. Amyloid-β (Aβ) and tau pathologies and neuroinflammation are three major hallmarks of Alzheimer's disease. Vast majority of the drug discovery efforts in the past decades have focused on targeting the Aβ pathology, but
Año de Inicio/Término: 2021-2025
Financiamiento/Sponsor: NIH
Rol del Usuario: INVESTIGADOR(A)
URL: https://reporter.nih.gov/search/obP95fHxCUe5W4z-qybM9w/project-details/11088880
DOI:

5R01AG074541-05